Mohammed Minhas N Kapadia, MD
Child & Adolescent Psychiatry · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kapadia’s office at (408) 666-6486 to ask if they take your plan before you enroll.
California Medical Board record
Licence A116504 · Current
Licensed to practise in California · since 2011 · expires 2027-04-30 · University of Karachi, Dow Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Money from drug and device companies
$373 in 2023
| 2023 | 3 | 6 | None | $373 |
| 2022 | 3 | 4 | None | $312 |
| 2021 | 1 | 6 | None | $412 |
| 2020 | 1 | 1 | None | $50 |
| 2019 | 2 | 13 | None | $954 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Neurocrine Biosciences | Ingrezza | $294 | 4 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $58 | 1 payment
|
| Iti | Caplyta | $21 | 1 payment
|
See all 6 published payments
| Janssen Pharmaceuticals | Meals · 2023-04-27 | Invega Sustenna | $58 |
| Neurocrine Biosciences | Meals · 2023-04-19 | Ingrezza | $138 |
| Neurocrine Biosciences | Meals · 2023-03-01 | Ingrezza | $3 |
| Neurocrine Biosciences | Meals · 2023-03-01 | Ingrezza | $14 |
| Neurocrine BioSciences | Meals · 2023-02-08 | Ingrezza | $139 |
| Iti | Meals · 2023-02-01 | Caplyta | $21 |
See earlier years (2022, 2021, 2020, 2019)
2022: $312
| Janssen Pharmaceuticals | Invega Sustenna | $169 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $125 | 1 payment
|
| Iti | Caplyta | $19 | 1 payment
|
2021: $412
| Janssen Pharmaceuticals | Invega Sustenna | $412 | 6 payments
|
2020: $50
| Indivior | Perseris | $50 | 1 payment
|
2019: $954
| Janssen Pharmaceuticals | Spravato | $841 | 12 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $113 | 1 payment
|
Professional record
- NPI
- 1760792170
- Licence
- CA A116504California A116504: Current · expires 2027-04-30
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084P0804X (2084P0804X)
- Mailing address
- 2100 Napa Vallejo Hwy., Napa, CA, 94558
- NPI first listed
- 2010-10-19
- NPI last updated
- 2019-03-28
This is when the NPI record was last certified, not a medical board exam.